Stock Price Quote

BACIL PHARMA LTD.

NSE : NABSE : 524516ISIN CODE : INE711D01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE10.200.2 (+2 %)
PREV CLOSE ( ) 10.00
OPEN PRICE ( ) 10.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 926
TODAY'S LOW / HIGH ( )10.20 10.20
52 WK LOW / HIGH ( ) 4.6810.29
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-05 1987
Management Info
- Chairman - Managing Director
Registered Office

Address 71 , Laxmi Building , 4th Floor,Sir P . M . Road,Fort,
Mumbai,
Maharashtra-400001

Phone 022 22618452 / 22661541

Email info@bacilpharma.com / bacilpha@yahoo.com

Website www.bacilpharma.com

Registrars Details
Bigshare Services Pvt Ltd
E-2/3, Ansa Industrial Estate,Saki Vihar Road,Saki Naka,Mumbai
Listing : BSE

NEWS

14Feb Bacil Pharma informs about newspaper c
Bacil Pharma has informed that it enclosed newspaper clipping for Un-aud..
10Nov Bacil Pharma informs about outcome of
Bacil Pharma has informed that the meeting of Board of Directors of the..
24Aug Bacil Pharma submits annual report and
Bacil Pharma has informed that it enclosed Notice of 36th Annual General..
17May Bacil Pharma informs about newspaper c
Bacil Pharma has informed that it enclosed newspaper clipping for Audite..
26Apr Bacil Pharma informs about compliance
Bacil Pharma has informed that it enclosed Compliance Certificate pursua..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-0.24-1.02
Gross Profit -0.24 -1.02
Operating Profit -0.23-0.99
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4569.90 (4.30%)
M.Cap ( in Cr)20906.26
Neuland Laboratories (BSE)
peergroup  7102.20 (0.54%)
M.Cap ( in Cr)9112.04
Bajaj Healthcare (BSE)
peergroup  356.30 (11.20%)
M.Cap ( in Cr)983.33
Caplin Point Lab (BSE)
peergroup  1452.35 (1.89%)
M.Cap ( in Cr)11029.40
Jenburkt Pharma (BSE)
peergroup  787.20 (3.23%)
M.Cap ( in Cr)347.41

Shareholding Pattern

NON-INSTITUTION 57.33%
PROMOTERS 42.67%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Bacil Pharma Ltd.

Bacil Pharma Ltd. was incorporated in the year 1987. Its today's share price is 10.2. Its current market capitalisation stands at Rs 6.01 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.1.15 Cr. The company's management includes Bhavana Tak, Lalit Jain, Shirish Shetye, Suman Shah, Prakash Shah.

It is listed on the BSE with a BSE Code of 524516 , NSE with an NSE Symbol of and ISIN of INE711D01018. It's Registered office is at 71 , Laxmi Building , 4th Floor,Sir P . M . Road,FortMumbai-400001, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AW Ketkar & Co, Laxmikant Kabra & Co, Laxmikant Kabra & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.